TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX:...

– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in cognition and...

CELEBRATION, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company...

CELEBRATION, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company...

DCM’s CCM360 platform named to Aspire Leaderboard for leadership among its peers in 10 of 13 industrial verticals BRAMPTON, Ontario — DATA...

CALGARY, Alberta, Oct. 03, 2025 (GLOBE NEWSWIRE) — Global Helium Corp. (“Global” or the “Company”) (CSE: HECO) and 2679158 Alberta Ltd....

Berlin, Germany and Cambridge, MA, USA, October 7, 2025 – Bayer AG and its wholly owned, independently operated subsidiary BlueRock Therapeutics...

MISSISSAUGA, Ontario — MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it has completed the Initial...

Chairman and managing director Bhupender Gupta addressing the shareholders said that the financial year 2024–25 was a defining year of operational...

Chairman and managing director Bhupender Gupta addressing the shareholders said that the financial year 2024–25 was a defining year of operational...